Skip to content

Treatment with phytoesterogen on vaginal atrophy in postmenopausal women

Effect of Fennel vaginal cream on treatment vaginal atrophy in postmenopausal women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014102919743N1
Enrollment
60
Registered
2014-11-04
Start date
2014-11-29
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy Vaginal inpost menopausal women. Postmenopausal Atrophic Vaginitis

Interventions

Intervention 1: fennel 7% vaginal cream one applicator once a day for 8 week. Intervention 2: placebo,vaginal cream,once a day for 8 week.
Treatment - Drugs
Placebo
fennel 7% vaginal cream one applicator once a day for 8 week
placebo,vaginal cream,once a day for 8 week.

Sponsors

Vice chancellor for research, Ahvaz JundiShapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: Age between 45 to 65, Amenorrhea at less 12 month or have hormone test with FSH level more than 40 unit, Presenting symptom of vaginal atrophy, Have Sexual activity and single partner? Exclusion criteria: Vaginal infection, Genital Abnormalities, The use of Sex Hormones within the 8 weeks preceding study, user of smoke and alcohol and etc ? Genital Bleeding or spotting of unknown Cause, Use of Phytoestrogens such as Soy, Red clover, Fenugreek, Vitex within the last one Month

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Vaginal Atrophy. Timepoint: Before intervention, Two weeks after the intervention, Four weeks after intervention, Eight weeks after intervention. Method of measurement: Kupperman Index Questionnaire.;Percentage of Maturity vaginal cells. Timepoint: Before and after eight weeks (end of intervention). Method of measurement: Vaginal smear.;Vaginal PH. Timepoint: Before and after eight weeks (end of intervention). Method of measurement: By PH meter strips.

Secondary

MeasureTime frame
Dyspareunia. Timepoint: Before intervention, Two weeks after the intervention, Four weeks after intervention, Eight weeks after intervention. Method of measurement: self-assessed 4-point scale of composite score.;Added at 2015-08-03: menopausal symptoms. Timepoint: Added at 2015-08-03: Before intervention, 2, 4, 8 weeks after intervention. Method of measurement: Added at 2015-08-03: Kupperman Index Questionnaire.;Added at 2015-08-03: Temperament. Timepoint: Added at 2015-08-03: Before and after intervention. Method of measurement: Added at 2015-08-03: Temperament questionnaires.;Added at 2015-08-03: severity of menopausal symptoms. Timepoint: Added at 2015-08-03: Before intervention, 2, 4, 8 weeks after intervention. Method of measurement: Added at 2015-08-03: Menopause Rating Scale (MRS) questionnaire.;Added at 2015-08-03: Sexual function. Timepoint: Added at 2015-08-03: Before and after intervention. Method of measurement: Added at 2015-08-03: Female Sexual Function Index (FSFI) questionnaire.;Added at 2015-08-03: Sexual satisfaction. Timepoint: Added at 2015-08-03: Before and after intervention. Method of measurement: Added at 2015-08-03: Larson's sexual satisfaction questioner.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasumeh yaralizadeh

Ahvaz Jundishapur University of Medical Sciences

yaralizadeh.m@ajums.ac.ir+98 61 3336 7543

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026